Oral β-hydroxybutyrate increases ketonemia, decreases visceral adipocyte volume and improves serum lipid profile in Wistar rats

• Published in: Nutrition & metabolism 2017-04, Vol.14 (1), p.31-31, Article 31
• Main Authors: Caminhotto, Rennan de Oliveira, Komino, Ayumi Cristina Medeiros, de Fatima Silva, Flaviane, Andreotti, Sandra, Sertié, Rogério Antônio Laurato, Boltes Reis, Gabriela, Lima, Fabio Bessa
• Format: Article
• Language: English
• Subjects: Acyl-CoA dehydrogenase; Adipocytes; Adiponectin; Adipose tissue (brown); Body fat; Body weight; Body weight gain; Body weight loss; Calories; Cardiomyopathy; Cell size; Cerebrospinal fluid; Cholesterol; Colorimetry; Diet; Experimental models; Food intake; HDL-cholesterol; Infants; Inflammation; Ketosis; Leukodystrophy; Lipids; Metabolism; Nutrition; Organic chemicals; Rodents; Visceral fat; β-hydroxybutyrate salts
• ISSN: 1743-7075; 1743-7075
• DOI: 10.1186/s12986-017-0184-4

Ketosis can be induced in humans and in animals by fasting or dietary interventions, such as ketogenic diets. However, the increasing interest on the ketogenic state has motivated the development of alternative approaches to rapidly increase ketonemia using less drastic interventions. Here, it was tested whether oral intake of a β-hydroxybutyrate (βHB) mineral salt mixture could increase ketonemia in Wistar rats without any other dietary changes, thereby being a useful model to study ketones effects alone on metabolism. βHB salts were orally administered to provoke elevation in the ketonemia. Effects of this intervention were tested acutely (by gavage) and chronically (4 weeks in drinking water). Acutely, a concomitant glucose overload was used to suppress endogenous ketogenesis and verify whether βHB salts were really absorbed or not. Long-term administration allowed to weekly evaluate the impact on ketonemia, blood glucose and, after 4 weeks, on body weight, visceral fat mass, lipid blood profile, serum lipolysis products and adiponectinemia. βHB salts increased ketonemia in acute and long-term administrations, improved blood lipid profile by raising HDL-cholesterol concentration and decreasing LDL/HDL ratio, while reduced visceral adipocyte volume. Mean ketonemia correlated positively with HDLc and negatively with adipocyte volume and serum lipolysis products. Oral βHB can rapidly increase ketonemia and, therefore, be used as an acute and long-term animal model of ketosis. Long-term treatment points to important beneficial effects of ketone bodies in serum lipid concentrations and visceral fat mass. These results may help to explain the metabolic adaptations following ketogenic diets, such as a better body fat control and a serum lipid profile improvement.